Curatis Holding AG (XSWX:CURN) ROC (Joel Greenblatt) %: -338.46% (As of Dec. 2025)


XSWX:CURN Curatis Holding AG XSWX:CURN
31 GF Score
Price CHF23.60
! 7 Warning Signs
View Full Analysis

What is Curatis Holding AG ROC (Joel Greenblatt) %?

Curatis Holding AG XSWX:CURN +3.51% 31 ROC (Joel Greenblatt) % is -338.46% as of Dec. 2025. GuruFocus rates XSWX:CURN with a GF Score™ of 31/100. The stock has 7 warning signs investors should review. Among 975 Drug Manufacturers companies, Curatis Holding AG ranks worse than 94.87% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Curatis Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -338.46%.

The historical rank and industry rank for Curatis Holding AG's ROC (Joel Greenblatt) % or its related term are showing as below:

XSWX:CURN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -507450   Med: -398930   Max: -1161.54
Current: -1161.54

During the past 5 years, Curatis Holding AG's highest ROC (Joel Greenblatt) % was -1161.54%. The lowest was -507450.00%. And the median was -398930.00%.

XSWX:CURN's ROC (Joel Greenblatt) % is ranked worse than
94.87% of 975 companies
in the Drug Manufacturers industry
Industry Median: 11.44 vs XSWX:CURN: -1161.54

Curatis Holding AG's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Curatis Holding AG  (XSWX:CURN) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Curatis Holding AG ROC (Joel Greenblatt) % Related Terms


Curatis Holding AG ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Curatis Holding AG's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curatis Holding AG ROC (Joel Greenblatt) % Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
0.00 -398,930.00 -507,450.00 0.00 -1,161.54

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,621,833.33 0.00 0.00 0.00 -338.46

XSWX:CURN vs ZTS, UTHR, VTRS: ROC (Joel Greenblatt) % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curatis Holding AG ROC (Joel Greenblatt) % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's ROC (Joel Greenblatt) % falls into.


XSWX:CURN
31GF Score
Curatis Holding AG XSWX:CURN
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curatis Holding AG ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.38 + 1.433 + 0) - (2.68 + 0 + 0.629)
=-0.496

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.43 + 2.01 + 0) - (1.762 + 0 + 1.548)
=0.13

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Curatis Holding AG for the quarter that ended in Dec. 2025 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.44/( ( (0 + max(-0.496, 0)) + (0 + max(0.13, 0)) )/ 1 )
=-0.44/( ( 0 + 0.13 )/ 1 )
=-0.44/0.13
=-338.46 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -338.46% mean?
Curatis Holding AG (XSWX:CURN) has a ROC (Joel Greenblatt) % of -338.46% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Curatis Holding AG and its competitors. According to the industry distribution chart, Curatis Holding AG ranks #925 out of 975 companies in the Drug Manufacturers industry, placing it in the top 94.9%.
Is Curatis Holding AG's ROC (Joel Greenblatt) % too high?
Curatis Holding AG's current ROC (Joel Greenblatt) % is -338.46%. Based on the distribution chart, Curatis Holding AG ranks #925 out of 975 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Curatis Holding AG has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Curatis Holding AG's ROC (Joel Greenblatt) % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Curatis Holding AG ranks #925 out of 975 companies for ROC (Joel Greenblatt) %. This places Curatis Holding AG in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 11.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 11.44, based on 975 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Curatis Holding AG and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 11.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curatis Holding AG's current ROC (Joel Greenblatt) % is -338.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curatis Holding AG stock overvalued right now?
Curatis Holding AG (XSWX:CURN) has a current ROC (Joel Greenblatt) % of -338.46%. The current ROC (Joel Greenblatt) % is -338.46%. Curatis Holding AG's overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Curatis Holding AG (XSWX:CURN), the current ROC (Joel Greenblatt) % is -338.46% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curatis Holding AG Business Description

Other Exchanges CURNz:UK0QNS:UK26U:Germany
Address Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical Company with two-pillar. On one hand, the Company trades and distributes specialty medicines in the rare disease and specialty medicines space i.e. acquires, licenses, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and specialty diseases in Switzerland. On the other hand, it is a drug development Company with a pipeline of product candidates, also predominantly in the orphan drug space.
31GF Score

Get the complete analysis for XSWX:CURN

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF23.60
Price